Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice

BACKGROUND: Kallistatin exerts beneficial effects on organ injury by inhibiting oxidative stress and inflammation. However, the role of kallistatin in atherosclerosis is largely unknown. Here, we investigated the role and mechanisms of kallistatin in patients with coronary artery disease (CAD), athe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yuyu, Li, Bing, Liu, Chang, Fu, Cong, Li, Pengfei, Guo, Youming, Ma, Genshan, Liu, Naifeng, Chao, Lee, Chao, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404169/
https://www.ncbi.nlm.nih.gov/pubmed/30554563
http://dx.doi.org/10.1161/JAHA.118.009562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404169/
https://www.ncbi.nlm.nih.gov/pubmed/30554563
http://dx.doi.org/10.1161/JAHA.118.009562

Ejemplares similares